Pyrimidine-containing compound biosynthetic process

pathway activity — cross-omics
GO:0072528Cross-omicsPROTEIN-MS → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Pyrimidine-containing compound biosynthetic process pathway is significantly associated with the RNA expression of multiple genes, with the CCRCC cohort showing a particularly strong set of associations.

The most reproducible pathway-associated genes across cancer lineages are CA4, LDB2, and SLC4A7, each associated with the pathway in up to 5 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Pyrimidine-containing compound biosynthetic process activity versus CA4 in CCRCC (Pearson r = -0.38).

Pathway-associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
CCRCCCA4 →-1.359-0.157<.001<.00134
UCECLDB2 →-0.797-0.250<.001<.00134
GBMSLC4A7 →+0.331+0.145.005.00134
GBMDKK3 →-0.730-0.247.001<.00134
PDACCENPF →+0.567+0.163.003<.00134
LSCCSLC25A19 →+0.361+0.152.003.00425
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0072528 vs CA4 — CCRCC

Per-sample scatter of Pyrimidine-containing compound biosynthetic process activity vs CA4 in CCRCC.

Explore this scatter interactively →

Exploration